View in EDS

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.

Saved in:
Bibliographic Details
Title: The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.
Authors: Hicks SW; ImmunoGen, Inc., Waltham, MA. Electronic address: stuart.hicks@immunogen.com., Lai KC; ImmunoGen, Inc., Waltham, MA., Gavrilescu LC; ImmunoGen, Inc., Waltham, MA., Yi Y; ImmunoGen, Inc., Waltham, MA., Sikka S; ImmunoGen, Inc., Waltham, MA., Shah P; ImmunoGen, Inc., Waltham, MA., Kelly ME; ImmunoGen, Inc., Waltham, MA., Lee J; ImmunoGen, Inc., Waltham, MA., Lanieri L; ImmunoGen, Inc., Waltham, MA., Ponte JF; ImmunoGen, Inc., Waltham, MA., Sloss CM; ImmunoGen, Inc., Waltham, MA., Romanelli A; ImmunoGen, Inc., Waltham, MA.
Source: Neoplasia (New York, N.Y.) [Neoplasia] 2017 Sep; Vol. 19 (9), pp. 661-671. Date of Electronic Publication: 2017 Jul 25.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5586 (Electronic) Linking ISSN: 14765586 NLM ISO Abbreviation: Neoplasia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28753442
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hicks+SW%22">Hicks SW</searchLink>; ImmunoGen, Inc., Waltham, MA. Electronic address: stuart.hicks@immunogen.com.<br /><searchLink fieldCode="AU" term="%22Lai+KC%22">Lai KC</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Gavrilescu+LC%22">Gavrilescu LC</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Yi+Y%22">Yi Y</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Sikka+S%22">Sikka S</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Shah+P%22">Shah P</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Kelly+ME%22">Kelly ME</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Lanieri+L%22">Lanieri L</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Ponte+JF%22">Ponte JF</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Sloss+CM%22">Sloss CM</searchLink>; ImmunoGen, Inc., Waltham, MA.<br /><searchLink fieldCode="AU" term="%22Romanelli+A%22">Romanelli A</searchLink>; ImmunoGen, Inc., Waltham, MA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100886622%22">Neoplasia (New York, N.Y.)</searchLink> [Neoplasia] 2017 Sep; Vol. 19 (9), pp. 661-671. <i>Date of Electronic Publication: </i>2017 Jul 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100886622 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5586 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214765586%22">14765586 </searchLink><i>NLM ISO Abbreviation: </i>Neoplasia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28753442
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.neo.2017.06.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 661
    Titles:
      – TitleFull: The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hicks SW
      – PersonEntity:
          Name:
            NameFull: Lai KC
      – PersonEntity:
          Name:
            NameFull: Gavrilescu LC
      – PersonEntity:
          Name:
            NameFull: Yi Y
      – PersonEntity:
          Name:
            NameFull: Sikka S
      – PersonEntity:
          Name:
            NameFull: Shah P
      – PersonEntity:
          Name:
            NameFull: Kelly ME
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Lanieri L
      – PersonEntity:
          Name:
            NameFull: Ponte JF
      – PersonEntity:
          Name:
            NameFull: Sloss CM
      – PersonEntity:
          Name:
            NameFull: Romanelli A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2017 Sep
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5586
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Neoplasia (New York, N.Y.)
              Type: main
ResultId 1